CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report)’s share price gapped up prior to trading on Monday . The stock had previously closed at $35.12, but opened at $37.5040. CochLear shares last traded at $37.5040, with a volume of 75,184 shares changing hands.
Wall Street Analyst Weigh In
CHEOY has been the subject of a number of recent research reports. UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. Zacks Research upgraded shares of CochLear to a “hold” rating in a research note on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy”.
Read Our Latest Stock Analysis on CochLear
CochLear Stock Performance
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- What Exactly Is Agentic AI, and Why Are Some Stocks Blowing Up Because of It?
- 2 Pick-and-Shovel Plays for Major Digital Infrastructure Buildout
- Best Buy’s AI Laptop Boost Sparks Hope for a BBY Turnaround
- SanDisk’s Stock and Short Interest Both at Record Highs —Do the Bears Know Something?
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
